Results 11 to 20 of about 25,127 (239)

Preventing peanut allergy [PDF]

open access: yesArchives of Disease in Childhood, 2015
The rising prevalence of food allergy and specifically peanut allergy has had significant implications for affected patients, families, and society. The current standard of care remains strict avoidance and the use of emergency medications for accidental ingestions.
Meng, Chen   +2 more
openaire   +4 more sources

Early Peanut Immunotherapy in Children (EPIC) trial: protocol for a pragmatic randomised controlled trial of peanut oral immunotherapy in children under 5 years of age

open access: yesBMJ Paediatrics Open, 2023
Introduction Food allergy is a major public health challenge in Australia. Despite widespread uptake of infant feeding and allergy prevention guidelines the incidence of peanut allergy in infants has not fallen, and prevalence of peanut allergy in school-
Natasha Bear   +2 more
doaj   +1 more source

Psychosocial and productivity impact of caring for a child with peanut allergy

open access: yesAllergy, Asthma & Clinical Immunology, 2020
Background Limited previous research has assessed the psychosocial burden and productivity impact of caring for a child with peanut allergy and factors associated with burden.
Sarah Acaster   +6 more
doaj   +1 more source

Bronchial hyperresponsiveness and asthma during oral immunotherapy for egg or peanut allergy in children

open access: yesClinical and Translational Allergy, 2022
Background Bronchial hyperresponsiveness (BHR) and asthma are frequently present in children with food allergy. We assessed BHR in children receiving oral immunotherapy (OIT) for persistent egg or peanut allergy and examined whether OIT affects asthma ...
Janne Burman   +6 more
doaj   +1 more source

An algorithm for diagnosing IgE-mediated food allergy in study participants who do not undergo food challenge. [PDF]

open access: yes, 2020
BACKGROUND: Food allergy diagnosis in clinical studies can be challenging. Oral food challenges (OFC) are time-consuming, carry some risk and may, therefore, not be acceptable to all study participants.
Batt, R   +9 more
core   +2 more sources

Peanut allergy: Beyond the oral immunotherapy plateau

open access: yesClinical and Translational Allergy, 2021
Background There are a lack of disease‐modifying treatments for peanut allergy, which is lifelong in most instances. Oral immunotherapy has remained at the forefront of prospective treatments, though its efficacy is consistently undermined by the risk of
Kelly Bruton   +4 more
doaj   +1 more source

Allergy to Peanuts imPacting Emotions And Life (APPEAL): The impact of peanut allergy on children, teenagers, adults and caregivers in the UK and Ireland.

open access: yesPLoS ONE, 2022
The Allergy to Peanuts imPacting Emotions And Life study (APPEAL) explored the psychosocial burden of living with self-reported peanut allergy experienced by children, teenagers, adults and caregivers in the UK and Ireland.
Marina Tsoumani   +9 more
doaj   +1 more source

Novel peanut-specific human IgE monoclonal antibodies enable screens for inhibitors of the effector phase in food allergy

open access: yesFrontiers in Immunology, 2022
Background10% of US residents have food allergies, including 2% with peanut allergy. Mast cell mediators released during the allergy effector phase drive allergic reactions.
Jada Suber   +11 more
doaj   +1 more source

The benefits of component-resolved diagnosis in diagnostics of peanut allergy

open access: yesJournal of Education, Health and Sport, 2022
Introduction: Why can a peanut allergy cause exceptionally severe reactions, but not to everyone? Is there a way to identify patients who might experience these reactions?
Magdalena Choina   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy